Next Article in Journal
Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism
Next Article in Special Issue
Cutthroat Trout Virus—Towards a Virus Model to Support Hepatitis E Research
Previous Article in Journal
The Immune Response in Measles: Virus Control, Clearance and Protective Immunity
Previous Article in Special Issue
A Single Lineage of Hepatitis E Virus Causes Both Outbreaks and Sporadic Hepatitis in Sudan
Review

Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations

Institute of Experimental Virology, Twincore—Centre for Experimental and Clinical Infection Research, a Joint Venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research, 30625 Hannover, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: Jacques Izopet
Viruses 2016, 8(10), 283; https://doi.org/10.3390/v8100283
Received: 18 August 2016 / Revised: 30 September 2016 / Accepted: 6 October 2016 / Published: 13 October 2016
(This article belongs to the Special Issue Recent Progress in Hepatitis E Virus Research)
Hepatitis E virus (HEV), an important agent of viral hepatitis worldwide, can cause severe courses of infection in pregnant women and immunosuppressed patients. To date, HEV infections can only be treated with ribavirin (RBV). Major drawbacks of this therapy are that RBV is not approved for administration to pregnant women and that the virus can acquire mutations, which render the intra-host population less sensitive or even resistant to RBV. One of the proposed modes of action of RBV is a direct mutagenic effect on viral genomes, inducing mismatches and subsequent nucleotide substitutions. These transition events can drive the already error-prone viral replication beyond an error threshold, causing viral population extinction. In contrast, the expanded heterogeneous viral population can facilitate selection of mutant viruses with enhanced replication fitness. Emergence of these mutant viruses can lead to therapeutic failure. Consequently, the onset of RBV treatment in chronically HEV-infected individuals can result in two divergent outcomes: viral extinction versus selection of fitness-enhanced viruses. Following an overview of RNA viruses treated with RBV in clinics and a summary of the different antiviral modes of action of this drug, we focus on the mutagenic effect of RBV on HEV intrahost populations, and how HEV is able to overcome lethal mutagenesis. View Full-Text
Keywords: hepatitis E virus; ribavirin; RNA viruses; mutagenesis; intra-host population hepatitis E virus; ribavirin; RNA viruses; mutagenesis; intra-host population
Show Figures

Figure 1

MDPI and ACS Style

Todt, D.; Walter, S.; Brown, R.J.P.; Steinmann, E. Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses 2016, 8, 283. https://doi.org/10.3390/v8100283

AMA Style

Todt D, Walter S, Brown RJP, Steinmann E. Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses. 2016; 8(10):283. https://doi.org/10.3390/v8100283

Chicago/Turabian Style

Todt, Daniel, Stephanie Walter, Richard J.P. Brown, and Eike Steinmann. 2016. "Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations" Viruses 8, no. 10: 283. https://doi.org/10.3390/v8100283

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop